5'-methylthioadenosine and Urethral Neoplasms

5'-methylthioadenosine has been researched along with Urethral Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, S; Bell, RH; Beltran, H; Bertino, JR; Brahmbhatt, S; Cheng, H; Chinnaiyan, AM; Collins, CC; Demichelis, F; Fazli, L; Gleave, M; Gout, PW; Haegert, A; Hirst, M; Hurtado-Coll, A; Lapuk, AV; Lubin, M; Maher, CA; Marra, M; Rubin, MA; Volik, SV; Wang, Y; Wu, C; Xue, H	1

Other Studies

1 other study(ies) available for 5'-methylthioadenosine and Urethral Neoplasms

Article	Year
Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target. Molecular cancer therapeutics, 2012, Volume: 11, Issue:3 Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p16; Deoxyadenosines; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neuroendocrine Tumors; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Sequence Analysis, DNA; Thioguanine; Thionucleosides; Treatment Outcome; Urethral Neoplasms; Xenograft Model Antitumor Assays	2012

Article

Year

Next generation sequencing of prostate cancer from a patient identifies a deficiency of methylthioadenosine phosphorylase, an exploitable tumor target.

Molecular cancer therapeutics, 2012, Volume: 11, Issue:3

Topics: Aged; Animals; Antineoplastic Combined Chemotherapy Protocols; Chromosome Deletion; Chromosomes, Human, Pair 9; Cyclin-Dependent Kinase Inhibitor p16; Deoxyadenosines; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Neuroendocrine Tumors; Prostatic Neoplasms; Purine-Nucleoside Phosphorylase; Sequence Analysis, DNA; Thioguanine; Thionucleosides; Treatment Outcome; Urethral Neoplasms; Xenograft Model Antitumor Assays

2012